Gemfibrozil
Lopid
Peroxisome Proliferator Receptor alpha Agonist
NADAC/unit
$0.1027
No Shortage
Tier 1: 61.7%
8 Manufacturers
8 ANDAs
vs. brand Lopid: Generic saves up to 99% per unit
Active Shortages
2026-02-10 Discontinuation of the manufacture of the drug., Pfizer Inc.
Generic Manufacturers
ASCENT PHARMACEUTICALS INCAUROBINDO PHARMA LTDCADILA PHARMACEUTICALS LTDCHARTWELL MOLECULES LLCEPIC PHARMA LLCIMPAX PHARMACEUTICALSINVAGEN PHARMACEUTICALS INCNORTHSTAR HEALTHCARE HOLDINGS LTDPFIZER PHARMACEUTICALS LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.